abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
90812: CEBPA Mutation Analysis Print View
Specimen Source      
SAMPLE ID      
CEBPA Mutation PCR  Not Detected   

PRIMARY
1 Whole Blood EDTA 5 (2) mL   Room Temperature - 7 Day(s)/Refrigerated - 7 Day(s)  
ALTERNATE

The CEBPA gene, a myeloid transcription factor, is mutated in a subset of acute myeloid leukemia (AML), particularly those with chromosome analyses showing normal diploid karyotype, Cytogenetically Normal (CN). CN-AML that have CEBPA mutations show favorable outcome compared to other groups of CN-AML. Testing for CEBPA mutation, along with NPM1 (16158 test code) and FLT3 mutations (test code 90574) is recommended for all patients with CN-AML.

5 mL EDTA (lavender-top) tube whole blood


Do not freeze. FFPE is a validated specimen type, however, it is not
routinely performed.
Cell Pellet Instructions: This assay is also designed for the
remnant cell pellet from Cytogenetics. The cell pellet usually
fixed should be transported at room temperature or refrigerated
to the laboratory as soon as possible. Please provide a copy of
the Cytogenetics report.


Reject Criteria: Gross hemolysis


Transport Temperature: Ship room temperature
Setup Schedule
Tuesday, Thursday, Saturday

Reported (Analytical Time)
3 days

CPT Code
81218

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database